--- title: Nori Health offers free access to smart chatbot for people with Crohn’s and Colitis during the crisis description: Today Nori Health has launched their free digital coach software for patients suffering from Crohn’s and Colitis during the COVID-19 crisis. Nori Health is an 8-week supportive program with a conversa image: https://news.lifesciencenewswire.com/hubfs/Imported_Blog_Media/nhexamp-1-1024x708.png --- [![Life Science Newswire 2](https://news.lifesciencenewswire.com/hs-fs/hubfs/Life%20Science%20Newswire%202.png?width=203&height=60&name=Life%20Science%20Newswire%202.png "Life Science Newswire 2")](https://lifesciencenewswire.com/) - [Newsroom](https://news.lifesciencenewswire.com/newsroom) - [Back to the main site](https://lifesciencenewswire.com/) ![LSNewswire-main-header-banner-v2-1](https://news.lifesciencenewswire.com/hubfs/LSNewswire-main-header-banner-v2-1.jpg "LSNewswire-main-header-banner-v2-1") # Newsroom #### Categories ![Arrow](https://cdn2.hubspot.net/hubfs/3842749/ps4-Pack/sidebar.svg "Arrow") #### Subscribe![](https://cdn2.hubspot.net/hubfs/3842749/ps4-Pack/subscribe-rss-button.svg) ![](https://cdn2.hubspot.net/hubfs/3842749/ps4-Pack/close-button.svg) ### Choose a Category - [Agriculture (1)](https://news.lifesciencenewswire.com/newsroom/tag/agriculture) - [Analytical Chemistry (42)](https://news.lifesciencenewswire.com/newsroom/tag/analytical-chemistry) - [Biomanufacturing (34)](https://news.lifesciencenewswire.com/newsroom/tag/biomanufacturing) - [biopharma (20)](https://news.lifesciencenewswire.com/newsroom/tag/biopharma) - [Bioprocessing (15)](https://news.lifesciencenewswire.com/newsroom/tag/bioprocessing) - [Biotechnology (244)](https://news.lifesciencenewswire.com/newsroom/tag/biotechnology) - [Cell Culture (9)](https://news.lifesciencenewswire.com/newsroom/tag/cell-culture) - [Clinical Diagnostics (36)](https://news.lifesciencenewswire.com/newsroom/tag/clinical-diagnostics) - [clinical research (6)](https://news.lifesciencenewswire.com/newsroom/tag/clinical-research) - [Clinical Research & Trials (108)](https://news.lifesciencenewswire.com/newsroom/tag/clinical-research-trials) - [Computing & Technology (62)](https://news.lifesciencenewswire.com/newsroom/tag/computing-it) - [Corporate, Finance & Investor (283)](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor) - [COVID-19 (86)](https://news.lifesciencenewswire.com/newsroom/tag/covid-19) - [Diagnostics & Hospital Laboratory (35)](https://news.lifesciencenewswire.com/newsroom/tag/diagnostics-hospital-laboratory) - [Drug Discovery & Development (147)](https://news.lifesciencenewswire.com/newsroom/tag/drug-discovery-development) - [Energy & Environment (15)](https://news.lifesciencenewswire.com/newsroom/tag/energy-environment) - [excipients (1)](https://news.lifesciencenewswire.com/newsroom/tag/excipients) - [Food & Beverage (8)](https://news.lifesciencenewswire.com/newsroom/tag/food-beverage) - [General Chemistry (7)](https://news.lifesciencenewswire.com/newsroom/tag/general-chemistry) - [General Laboratory (55)](https://news.lifesciencenewswire.com/newsroom/tag/general-laboratory) - [General Science (5)](https://news.lifesciencenewswire.com/newsroom/tag/general-science) - [Healthcare (132)](https://news.lifesciencenewswire.com/newsroom/tag/healthcare) - [Hospital Management (6)](https://news.lifesciencenewswire.com/newsroom/tag/hospital-management) - [Life Science (26)](https://news.lifesciencenewswire.com/newsroom/tag/life-science) - [Manufacturing (2)](https://news.lifesciencenewswire.com/newsroom/tag/manufacturing) - [Materials Science (2)](https://news.lifesciencenewswire.com/newsroom/tag/materials-science) - [Medical Devices & Technology (25)](https://news.lifesciencenewswire.com/newsroom/tag/medical-devices-technology) - [Microbiology & Infection Control (18)](https://news.lifesciencenewswire.com/newsroom/tag/microbiology-infection-control) - [Microscopy & Imaging (47)](https://news.lifesciencenewswire.com/newsroom/tag/microscopy-imaging) - [Nanotech (2)](https://news.lifesciencenewswire.com/newsroom/tag/nanotech) - [Omics & Genetics (86)](https://news.lifesciencenewswire.com/newsroom/tag/omics-genetics) - [Pathology (5)](https://news.lifesciencenewswire.com/newsroom/tag/pathology) - [Pharma (114)](https://news.lifesciencenewswire.com/newsroom/tag/pharma) - [Pharmacy (4)](https://news.lifesciencenewswire.com/newsroom/tag/pharmacy) - [Research (47)](https://news.lifesciencenewswire.com/newsroom/tag/research) - [Veterinary (5)](https://news.lifesciencenewswire.com/newsroom/tag/veterinary) - [Water (8)](https://news.lifesciencenewswire.com/newsroom/tag/water) See all ### Subscribe to Email Updates - ##### SHARE - - - # [Nori Health offers free access to smart chatbot for people with Crohn’s and Colitis during the crisis](https://news.lifesciencenewswire.com/newsroom/healthcare/nori-health-offers-free-access-to-smart-chatbot-for-people-with-crohns-and-colitis-during-the-crisis) May 19, 2020 *This initiative is launched in the UK on a non-profit basis with the support of the Primary Care Society for Gastroenterology (PCSG).* [![](https://news.lifesciencenewswire.com/hs-fs/hubfs/Imported_Blog_Media/nhexamp-1-1024x708.png?width=623&height=431&name=nhexamp-1-1024x708.png)](https://drive.google.com/file/d/13bCqspupTbDaoOFR-0zf0Co0NIFbcthF/view) *Caption: An example chat conversation with Nori. To download image, click [here](https://drive.google.com/file/d/13bCqspupTbDaoOFR-0zf0Co0NIFbcthF/view).* Covid-19 forced the most vulnerable in our society to go into self-isolation, such as the 600.000 people living in the UK with Inflammatory Bowel Disease (IBD) of which Crohn’s and Colitis are most common. To help manage their disease more effectively during the crisis, the digital coach from Nori Health is made available for free from their website (use access code UKFREE) with the support of the Primary Care Society for Gastroenterology and its Chair, Dr Kevin Barrett. Nori Health is an 8-week supportive program with a conversational (chatbot) coach for people living with Crohn's or Colitis. This is done through daily chat conversations with Nori across 100+ evidence-based topics proven to impact quality of life. **The challenges with IBD and Covid-19** IBD concerns inflammation of the gut and symptoms include pain or cramps, weight loss, and extreme tiredness. The enforced lockdown causes additional stress and there is also the hidden cost of not managing the symptoms or flare-ups in a timely manner. [A recent study](https://www.crohn-colitis.nl/nieuws/resultaten-ccuvn-peiling-uitgestelde-zorg/) by the Dutch IBD Foundation regarding the current crisis showed that over 80% of patients have serious concerns about their health. On top of this there are many patients involved in medication trials to discover new treatment, and the majority of these trials have been paused – leaving patients exposed to uncertainty. Sander van der Marel, gastroenterologist at Haaglanden Hospital in The Netherlands comments: "With weeks and potentially months of isolation ahead, digital tools like Nori Health can provide extended care encouraging a healthy lifestyle and offering mental support while also helping to relieve pressure on already overstretched healthcare workers." Free registration to the Nori Health program is available in May and June through [www.norihealth.com](https://www.norihealth.com/) by using access code UKFREE. Example image is attached to this release. For additional downloads: [https://norihealth.com/press/](https://norihealth.com/press/) **About Nori Health** Nori Health was founded in The Netherlands in December 2017 by Roeland Pater, a Crohn’s Disease sufferer himself in need for better solutions to self-manage the condition. The Nori Health program is the only CE-certified digital program for patients with Crohn’s or Colitis. The program was successfully tested in a virtual trial in partnership with the Crohn’s and Colitis Foundation of the Netherlands in January 2019. Nori Health is currently provided to patients in both live treatment and medication trials in partnership with pharmaceutical companies. **About PCSG - Primary Care Society for Gastroenterology** The Primary Care Society for Gastroenterology is a not for profit members society founded in 1985 ( [www.pcsg.org.uk](http://www.pcsg.org.uk/) ). As the voice of primary care gastroenterology, we engage with a wide range of organisations to promote our main purpose, "Improving Gut Health for Everyone". The society is authoritative, collaborative and innovative, and has built relationships with charities, Royal Colleges, NICE and other key national organisations to deliver a range of activities that meet this purpose. Today the society has a large and growing membership, an active and informative website and a well respected journal, The Digest. Categories: [Healthcare](https://news.lifesciencenewswire.com/newsroom/tag/healthcare), [COVID-19](https://news.lifesciencenewswire.com/newsroom/tag/covid-19) ##### Browse more news ## Recent releases #### [Enhanced Compliance Inc. (ECI) Appoints Taranjit S. Samra as Head of Medical Device Software Enginee...](https://news.lifesciencenewswire.com/newsroom/enhanced-compliance-inc.-eci-appoints-taranjit-s.-samra-as-head-of-medical-device-software-engineering-cybersecurity-and-ai) July 6, 2026 Strengthens ECI’s AI & Digital Transformation capabilities to help clients develop the next generation of software-enabled medical technologies En... ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/enhanced-compliance-inc.-eci-appoints-taranjit-s.-samra-as-head-of-medical-device-software-engineering-cybersecurity-and-ai) #### [Alithea Genomics Launches Early Access Program for MERCURIUS™ 1536 DRUG-seq, Bringing Transcriptomic...](https://news.lifesciencenewswire.com/newsroom/alithea-genomics-launches-early-access-program-for-mercurius-1536-drug-seq-bringing-transcriptomics-to-compound-screening-scale) June 16, 2026 New ultra-high-throughput kit enables discovery teams to generate transcriptome-wide compound-response data directly from 1536-well plates Alithea Gen... ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/alithea-genomics-launches-early-access-program-for-mercurius-1536-drug-seq-bringing-transcriptomics-to-compound-screening-scale) #### [Arscience Biotherapeutics Appoints Gustavo Mahler as Chief Executive Officer](https://news.lifesciencenewswire.com/newsroom/arscience-biotherapeutics-appoints-gustavo-mahler-as-chief-executive-officer) June 16, 2026 Seasoned Biopharmaceutical Leader and Board Director Steps Up to Lead the Company’s Next Phase of Growth in Customized Interleukin Therapies ARScience... ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/arscience-biotherapeutics-appoints-gustavo-mahler-as-chief-executive-officer) ![LS-Newswire-reverse](https://news.lifesciencenewswire.com/hs-fs/hubfs/raw_assets/public/LifeScienceNewswire_June2020/images/LS-Newswire-reverse.png?width=150&name=LS-Newswire-reverse.png "LS-Newswire-reverse") Life Science Newswire is a division of BioStrata Ltd, with company registered address: 3rd Floor, 1 Ashley Road, Altrincham, Cheshire, England, WA14 2DT. Company registration number: 8233225  #### Useful information - [Cookie and privacy policy](https://lifesciencenewswire.com/cookie-privacy-policy/) - [Website terms and conditions](https://lifesciencenewswire.com/terms-and-conditions) - [Promotion terms and conditions](https://lifesciencenewswire.com/promotion_terms/)